Medical Device News Magazine

Keri P Mattox Appointed Senior VP of Investor Relations and Chief Communications Officer at Zimmer Biomet

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Keri P Mattox has been appointed to the newly created position of Senior Vice President, Investor Relations and Chief Communications Officer.

Keri P Mattox joins Zimmer Biomet from W2O Group, an international healthcare-focused marketing and communications firm, where she served as Global Lead, Integrated Corporate Communications and was responsible for strategically shaping and expanding the firm’s global corporate communications, investor relations, crisis communications, board engagement and corporate social responsibility/foundation capabilities and offering.

“Keri brings deep expertise and a history of successfully driving effective investor relations, communications and corporate social responsibility programs,” said Suky Upadhyay, CFO of Zimmer Biomet. “Her proven track record of integrating investor relations and communications strategies will be critical as we continue to focus on transforming our business.”

Ms. Mattox comes to Zimmer Biomet with more than two decades in investor relations and communications across healthcare distribution, pharmaceuticals, biotech and medical devices. In her new role at Zimmer Biomet, she is responsible for strategically integrating, aligning and driving investor relations, communications and philanthropy functions and activities.

Coleman Lannum will be retiring from his position of Senior Vice President, Investor Relations, but will work closely with Ms. Mattox during a transition period.

Prior to W2O, Ms. Mattox was Vice President, Corporate & Investor Relations at AmerisourceBergen, a healthcare company ranked #10 on the Fortune 500 in 2019 with nearly $170 billion in annual revenue. She also held executive leadership level positions at Endo International and Auxilium Pharmaceuticals and spent more than 10 years at communications agencies in leadership positions.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”